JENNIFER EADDY: Open Payments
NPI 1144825563 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 11 payments from 7 companies in 2025. Trend: 2023 $481 · 2024 $748 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $158 |
| Phathom Pharmaceuticals, Inc. | 1 | $121 |
| Boston Scientific Corporation | 1 | $118 |
| Organon LLC | 3 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Alkermes, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: VRAYLAR, VOQUEZNA, AMS 700, NEXPLANON, CAPLYTA, LYBALVI, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
